Diabetic patient without semaglutide: where’s the real issue?

Authors

DOI:

https://doi.org/10.32385/rpmgf.v39i1.13670

Keywords:

Semaglutide, Diabetes mellitus type 2, Ethics, Obesity, Overweight

Abstract

Não aplicável

Downloads

Download data is not yet available.

References

INFARMED. Indisponibilidade de medicamentos contendo semaglutido (Ozempic): circular informativa nº 125/CD/100.20.200 de 24/10/2022 [homepage]. Lisboa: INFARMED; 2022 [updated 2022 Oct 25; cited 2022 Nov 1]. Available from: https://www.infarmed.pt/web/infarmed/infarmed/-/journal_content/56/15786/7598121

Sattar N, Lee MM, Kristensen SL, Branch KR, Del Prato S, Khurmi NS, et al. Cardiovascular, mortality, and kidney outcomes with GLP-1 receptor agonists in patients with type 2 diabetes: a systematic review and meta-analysis of randomised trials. Lancet Diabetes Endocrinol. 2021;9(10):653-62.

Campos A. Medicamento para diabetes é usado para perder peso: despesa do SNS dispara [homepage]. Público; 2022 Oct 24 [cited 2022 Nov 11]. Available from: https://www.publico.pt/2022/10/24/sociedade/noticia/medicamento-diabetes-usado-perder-peso-despesa-sns-dispara-2025084

Raposo JF. Diabetes: factos e números 2016, 2017 e 2018. Rev Port Diabetes. 2020;15(1):19-27.

Gaio V, Antunes L, Namorado S, Barreto M, Gil A, Kyslaya I, et al. Prevalence of overweight and obesity in Portugal: results from the First Portuguese Health Examination Survey (INSEF 2015). Obes Res Clin Pract. 2018;12(1):40-50.

Carballo F, Júdez J, de Abajo F, Violán C. Uso racional de recursos [Rational use of health care resources]. Med Clin. 2001;117(17):662-75. Spanish

Downloads

Published

2023-03-07

Issue

Vol. 39 No. 1 (2023): Revista Portuguesa de Medicina Geral e Familiar

Section

Letter to Director

License

Copyright (c) 2023 Portuguese Journal of Family Medicine and General Practice

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

The authors will assign to the RPMGF the sole right to publish and distribute the content of the manuscript specified in this declaration via physical, electronic, broadcasting or any other medium that may come into existence. They also grant the RPMGF the right to use and exploit this manuscript, in particular by assigning, selling or licensing its content. This permission is permanent and takes effect from the moment the manuscript is submitted, has the maximum duration allowed by applicable Portuguese or international law and is of worldwide scope. The authors further declare that this assignment is made free of charge. If the RPMGF informs the authors that it is not going to publish their manuscript, the exclusive assignment of rights ceases forthwith.

The authors authorise the RPMGF (or any entity it may appoint) to act on their behalf when it believes that copyright may have been infringed.

 

How to Cite

Diabetic patient without semaglutide: where’s the real issue?. (2023). Portuguese Journal of Family Medicine and General Practice, 39(1), 91-3. https://doi.org/10.32385/rpmgf.v39i1.13670